b'<?xml version="1.0" ?>\n<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">\n<PubmedArticleSet>\n<PubmedArticle>\n    <MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM">\n        <PMID Version="1">31133850</PMID>\n        <DateRevised>\n            <Year>2020</Year>\n            <Month>02</Month>\n            <Day>25</Day>\n        </DateRevised>\n        <Article PubModel="Electronic-eCollection">\n            <Journal>\n                <ISSN IssnType="Print">1663-9812</ISSN>\n                <JournalIssue CitedMedium="Print">\n                    <Volume>10</Volume>\n                    <PubDate>\n                        <Year>2019</Year>\n                    </PubDate>\n                </JournalIssue>\n                <Title>Frontiers in pharmacology</Title>\n                <ISOAbbreviation>Front Pharmacol</ISOAbbreviation>\n            </Journal>\n            <ArticleTitle>Nanofibrous Scaffolds Support a 3D <i>in vitro</i> Permeability Model of the Human Intestinal Epithelium.</ArticleTitle>\n            <Pagination>\n                <MedlinePgn>456</MedlinePgn>\n            </Pagination>\n            <ELocationID EIdType="doi" ValidYN="Y">10.3389/fphar.2019.00456</ELocationID>\n            <Abstract>\n                <AbstractText>Advances in drug research not only depend on high throughput screening to evaluate large numbers of lead compounds but also on the development of <i>in vitro</i> models which can simulate human tissues in terms of drug permeability and functions. Potential failures, such as poor permeability or interaction with efflux drug transporters, can be identified in epithelial Caco-2 monolayer models and can impact a drug candidate\'s progression onto the next stages of the drug development process. Whilst monolayer models demonstrate reasonably good prediction of <i>in vivo</i> permeability for some compounds, more developed <i>in vitro</i> tools are needed to assess new entities that enable closer <i>in vivo in vitro</i> correlation. In this study, an <i>in vitro</i> model of the human intestinal epithelium was developed by utilizing nanofibers, fabricated using electrospinning, to mimic the structure of the basement membrane. We assessed Caco-2 cell response to these materials and investigated the physiological properties of these cells cultured on the fibrous supports, focusing on barrier integrity and drug-permeability properties. The obtained data illustrate that 2D Caco-2 Transwell<sup>\xc2\xae</sup> cultures exhibit artificially high trans-epithelial electrical resistance (TEER) compared to cells cultured on the 3D nanofibrous scaffolds which show TEER values similar to <i>ex vivo</i> porcine tissue (also measured in this study). Furthermore, our results demonstrate that the 3D nanofibrous scaffolds influence the barrier integrity of the Caco-2 monolayer to confer drug-absorption properties that more closely mimic native gut tissue particularly for studying passive epithelial transport. We propose that this 3D model is a suitable <i>in vitro</i> model for investigating drug absorption and intestinal metabolism.</AbstractText>\n            </Abstract>\n            <AuthorList CompleteYN="Y">\n                <Author ValidYN="Y">\n                    <LastName>Patient</LastName>\n                    <ForeName>Jamie D</ForeName>\n                    <Initials>JD</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>School of Pharmacy, University of Nottingham, Nottingham, United Kingdom.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Hajiali</LastName>\n                    <ForeName>Hadi</ForeName>\n                    <Initials>H</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>School of Pharmacy, University of Nottingham, Nottingham, United Kingdom.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Harris</LastName>\n                    <ForeName>Kate</ForeName>\n                    <Initials>K</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>AstraZeneca, Macclesfield, United Kingdom.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Abrahamsson</LastName>\n                    <ForeName>Bertil</ForeName>\n                    <Initials>B</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>AstraZeneca, M\xc3\xb6lndal, Sweden.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Tannergren</LastName>\n                    <ForeName>Christer</ForeName>\n                    <Initials>C</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>AstraZeneca, M\xc3\xb6lndal, Sweden.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>White</LastName>\n                    <ForeName>Lisa J</ForeName>\n                    <Initials>LJ</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>School of Pharmacy, University of Nottingham, Nottingham, United Kingdom.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Ghaemmaghami</LastName>\n                    <ForeName>Amir M</ForeName>\n                    <Initials>AM</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>School of Life Sciences, Queen\'s Medical Centre, University of Nottingham, Nottingham, United Kingdom.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Williams</LastName>\n                    <ForeName>Philip M</ForeName>\n                    <Initials>PM</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>School of Pharmacy, University of Nottingham, Nottingham, United Kingdom.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Roberts</LastName>\n                    <ForeName>Clive J</ForeName>\n                    <Initials>CJ</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>School of Pharmacy, University of Nottingham, Nottingham, United Kingdom.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Rose</LastName>\n                    <ForeName>Felicity R A J</ForeName>\n                    <Initials>FRAJ</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>School of Pharmacy, University of Nottingham, Nottingham, United Kingdom.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n            </AuthorList>\n            <Language>eng</Language>\n            <PublicationTypeList>\n                <PublicationType UI="D016428">Journal Article</PublicationType>\n            </PublicationTypeList>\n            <ArticleDate DateType="Electronic">\n                <Year>2019</Year>\n                <Month>05</Month>\n                <Day>10</Day>\n            </ArticleDate>\n        </Article>\n        <MedlineJournalInfo>\n            <Country>Switzerland</Country>\n            <MedlineTA>Front Pharmacol</MedlineTA>\n            <NlmUniqueID>101548923</NlmUniqueID>\n            <ISSNLinking>1663-9812</ISSNLinking>\n        </MedlineJournalInfo>\n        <KeywordList Owner="NOTNLM">\n            <Keyword MajorTopicYN="N">Caco-2 cell line</Keyword>\n            <Keyword MajorTopicYN="N">barrier integrity</Keyword>\n            <Keyword MajorTopicYN="N">electrospun scaffolds</Keyword>\n            <Keyword MajorTopicYN="N">in vitro model</Keyword>\n            <Keyword MajorTopicYN="N">permeability</Keyword>\n        </KeywordList>\n    </MedlineCitation>\n    <PubmedData>\n        <History>\n            <PubMedPubDate PubStatus="received">\n                <Year>2018</Year>\n                <Month>11</Month>\n                <Day>23</Day>\n            </PubMedPubDate>\n            <PubMedPubDate PubStatus="accepted">\n                <Year>2019</Year>\n                <Month>04</Month>\n                <Day>11</Day>\n            </PubMedPubDate>\n            <PubMedPubDate PubStatus="entrez">\n                <Year>2019</Year>\n                <Month>5</Month>\n                <Day>29</Day>\n                <Hour>6</Hour>\n                <Minute>0</Minute>\n            </PubMedPubDate>\n            <PubMedPubDate PubStatus="pubmed">\n                <Year>2019</Year>\n                <Month>5</Month>\n                <Day>28</Day>\n                <Hour>6</Hour>\n                <Minute>0</Minute>\n            </PubMedPubDate>\n            <PubMedPubDate PubStatus="medline">\n                <Year>2019</Year>\n                <Month>5</Month>\n                <Day>28</Day>\n                <Hour>6</Hour>\n                <Minute>1</Minute>\n            </PubMedPubDate>\n        </History>\n        <PublicationStatus>epublish</PublicationStatus>\n        <ArticleIdList>\n            <ArticleId IdType="pubmed">31133850</ArticleId>\n            <ArticleId IdType="doi">10.3389/fphar.2019.00456</ArticleId>\n            <ArticleId IdType="pmc">PMC6524416</ArticleId>\n        </ArticleIdList>\n        <ReferenceList>\n            <Reference>\n                <Citation>Curr Biol. 1999 Apr 8;9(7):R242-4</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">10209113</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Adv Drug Deliv Rev. 2001 Mar 1;46(1-3):27-43</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">11259831</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>J Pharmacol Toxicol Methods. 2000 Jul-Aug;44(1):301-12</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">11274897</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Biomaterials. 2002 Jun;23(12):2485-97</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">12033596</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Pharm Res. 2003 Aug;20(8):1192-9</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">12948017</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Drug Discov Today. 2005 Mar 1;10(5):335-43</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">15749282</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Toxicol In Vitro. 2005 Aug;19(5):675-84</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">15896555</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Am J Pathol. 2006 Mar;168(3):715-7</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">16507886</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>AAPS J. 2006 Jan 13;8(1):E1-13</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">16584115</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Biochem Biophys Res Commun. 1991 Mar 29;175(3):880-5</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">1673839</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Am J Physiol Gastrointest Liver Physiol. 2007 Jan;292(1):G173-81</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">16901995</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Colloids Surf B Biointerfaces. 2007 Mar 15;55(1):90-7</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">17207976</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Nat Protoc. 2007;2(9):2111-9</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">17853866</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>AAPS J. 2010 Dec;12(4):670-8</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">20811966</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>J Mech Behav Biomed Mater. 2011 Apr;4(3):340-51</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">21316622</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Am J Physiol Cell Physiol. 2011 Jun;300(6):C1404-14</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">21346149</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>J Biomed Mater Res B Appl Biomater. 2011 May;97(2):201-14</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">21391300</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Int J Nanomedicine. 2011;6:2133-41</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">22114477</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Eur J Pharm Sci. 2012 Aug 15;46(5):367-73</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">22418036</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Lab Chip. 2012 Jun 21;12(12):2165-74</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">22434367</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Biotechnol Bioeng. 2012 Sep;109(9):2173-8</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">22488418</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Eur J Pharm Sci. 2013 Jan 23;48(1-2):166-80</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">23103351</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Tissue Eng Part C Methods. 2013 Sep;19(9):708-19</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">23350801</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Exp Cell Res. 2014 Apr 15;323(1):218-31</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">24582861</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Mol Pharm. 2014 Jul 7;11(7):2082-91</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">24628276</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Am J Physiol Lung Cell Mol Physiol. 2014 Jul 1;307(1):L38-47</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">24793171</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Biofabrication. 2014 Sep;6(3):035014</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">24925127</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Eur J Pharm Sci. 2014 Oct 15;63:167-77</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">25046168</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Pharm Res. 2015 Feb;32(2):516-27</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">25190006</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Vet Pathol. 2015 May;52(3):445-55</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">25428410</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>J Lab Autom. 2015 Apr;20(2):107-26</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">25586998</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Biomacromolecules. 2015 Mar 9;16(3):936-43</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">25658494</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Acta Biomater. 2016 Apr 1;34:41-52</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">26196081</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>J Biomed Mater Res A. 2016 Apr;104(4):901-9</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">26650896</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Drug Metab Dispos. 2016 Mar;44(3):476-80</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">26842595</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Nat Commun. 2016 May 11;7:11535</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">27168102</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Eur J Pharm Biopharm. 2017 May;114:38-42</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">28088633</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Drug Metab Dispos. 2017 Apr;45(4):353-360</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">28153842</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>iScience. 2018 Apr 27;2:156-167</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">30428372</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Pharm Res. 1993 Aug;10(8):1123-9</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">8415396</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Pharm Res. 1997 May;14(5):667-71</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">9165541</ArticleId>\n                </ArticleIdList>\n            </Reference>\n        </ReferenceList>\n    </PubmedData>\n</PubmedArticle>\n\n</PubmedArticleSet>'